PEA & ALA II
Natural health product licensed in Canada
- Other names
- PEA & ALA, PEA + Alpha Lipoic Acid
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80096765
- Status
- Active licence
- Licence date
- 22 January 2020
- Revision date
- Not provided
- Form
- Capsule, remplie de liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-(2-Hydroxyéthyl)hexadécanamide Source : Palmitoyléthanolamide | 300 mg | Not calculated |
Non-medicinal ingredients
Stéaryl fumarate de sodium, Hypromellose, Vitamine E, Glycérol, Palmitate d'ascorbyle, Extrait de romarin, Dioxyde de silicium, Acide oléanolique, Poudre de racine de carotte, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Provides antioxidants. Helps to promote healthy glucose metabolism. Studies show that PEA may be used as an anti-inflammatory to help relieve pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes or if symptoms persist or worsen. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of serious low blood sugar).
Source
Official Health Canada record, licence 80096765
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.